|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
NLM282377271 |
| 003 |
DE-627 |
| 005 |
20240318233232.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231225s2018 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1002/adma.201706759
|2 doi
|
| 028 |
5 |
2 |
|a pubmed24n1334.xml
|
| 035 |
|
|
|a (DE-627)NLM282377271
|
| 035 |
|
|
|a (NLM)29582476
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Fang, Ronnie H
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Cell Membrane Coating Nanotechnology
|
| 264 |
|
1 |
|c 2018
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 07.03.2019
|
| 500 |
|
|
|a Date Revised 18.03.2024
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a © 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
|
| 520 |
|
|
|a Nanoparticle-based therapeutic, prevention, and detection modalities have the potential to greatly impact how diseases are diagnosed and managed in the clinic. With the wide range of nanomaterials available, the rational design of nanocarriers on an application-specific basis has become increasingly commonplace. Here, a comprehensive overview is provided on an emerging platform: cell-membrane-coating nanotechnology. As a fundamental unit of biology, cells carry out a wide range of functions, including the remarkable ability to interface and interact with their surrounding environment. Instead of attempting to replicate such functions via synthetic techniques, researchers are now directly leveraging naturally derived cell membranes as a means of bestowing nanoparticles with enhanced biointerfacing capabilities. This top-down technique is facile, highly generalizable, and has the potential to greatly augment existing nanocarriers. Further, the introduction of a natural membrane substrate onto nanoparticles surfaces has enabled additional applications beyond those traditionally associated with nanomedicine. Despite its relative youth, there exists an impressive body of literature on cell membrane coating, which is covered here in detail. Overall, there is still significant room for development, as researchers continue to refine existing workflows while finding new and exciting applications that can take advantage of this developing technology
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Review
|
| 650 |
|
4 |
|a biomimetic nanomedicine
|
| 650 |
|
4 |
|a detoxification
|
| 650 |
|
4 |
|a drug delivery
|
| 650 |
|
4 |
|a immunotherapy
|
| 650 |
|
4 |
|a medical imaging
|
| 700 |
1 |
|
|a Kroll, Ashley V
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Gao, Weiwei
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Zhang, Liangfang
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Advanced materials (Deerfield Beach, Fla.)
|d 1998
|g 30(2018), 23 vom: 26. Juni, Seite e1706759
|w (DE-627)NLM098206397
|x 1521-4095
|7 nnns
|
| 773 |
1 |
8 |
|g volume:30
|g year:2018
|g number:23
|g day:26
|g month:06
|g pages:e1706759
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1002/adma.201706759
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 30
|j 2018
|e 23
|b 26
|c 06
|h e1706759
|